PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy
PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy
Recruiting · NCT04745949 · Registry updated 2026-02-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy | Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recruiting | Phase 2 | 2026-02-19 | NCT04745949 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| M.D. Anderson Cancer Center | 1145 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| M D Anderson Cancer Center | Houston | United States | 667 |